Coates, L., Rahman, P., Psaradellis, E., Rampakakis, E., Osborne, B., Lehman, A., & Nantel, F. (2018). Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab. Oxford University Press.
Chicago-referens (17:e uppl.)Coates, L., P. Rahman, E. Psaradellis, E. Rampakakis, B. Osborne, A. Lehman, och F. Nantel. Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab. Oxford University Press, 2018.
MLA-referens (9:e uppl.)Coates, L., et al. Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab. Oxford University Press, 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.